| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Clinica Neurologica, Department of Neuroscience (Drs. Caramia, Palmieri, Desiato, Iani, Scalise, Telera, and Bernardi), Università di Roma Tor Vergata; and the IRCCS (Drs. Caramia, Palmieri, Scalise, Telera, and Bernardi), S. Lucia, Rome, Italy.
Address correspondence and reprint requests to Dr. M. Donatella Caramia, Dipartimento di Neuroscienze, Clinica Neurologica c/o Ospedale S. Eugenio, Piazzale dell’Umanesimo 10, 00144 Roma-Italia; e-mail: mwjones{at}ats.it
OBJECTIVE: To reverse the profile of abnormal intracortical excitability in patients with ALS by administering drugs that promote GABAergic transmission.
BACKGROUND: Transcranial magnetic stimulation (TMS) has revealed abnormalities of cortical inhibition in ALS, a reduction of the silent period, and the absence of intracortical inhibition normally occurring in response to paired TMS. Impaired inhibitory transmission could play a role in the physiopathology of this illness.
METHODS: Using paired TMS with conditioning stimuli from 1-to-6-msec-interstimulus intervals, we investigated 16 patients with ALS. The protocol included: (1) the "drug-free" profile of paired TMS; (2) paired TMS 30 minutes after the intake of diazepam (3.5 mg); (3) paired TMS after 3 weeks’ treatment with gabapentin (GBP) (600 mg/day) or riluzole (50 mg/twice a day).
RESULTS: Intracortical inhibition is lost in patients with ALS, and this abnormal profile is reversed by diazepam or sustained treatment with GBP. We also noted that motor-evoked potential amplitudes to single stimuli increased (p < 0.01) after diazepam and GBP.
CONCLUSIONS: The demonstration of pharmacologic reversal of hyperexcitability in patients with ALS makes a potentially significant contribution toward understanding the pathophysiology of a disease that has so far eluded an effective cure.
Key words: ALS—Paired transcranial magnetic stimulation—Intracortical inhibition—Motor evoked potential—GABAergic drugs
This article has been cited by other articles:
|
|
 |
|
  J Liepert, D Mingers, C Heesen, T Baumer, and C Weiller Motor cortex excitability and fatigue in multiple sclerosis: a transcranial magnetic stimulation study Multiple Sclerosis, June 1, 2005; 11(3): 316 - 321. [Abstract] [PDF]
|
|
|
|
 |
|
 T. Z. Su, M. R. Feng, and M. L. Weber Mediation of Highly Concentrative Uptake of Pregabalin by L-Type Amino Acid Transport in Chinese Hamster Ovary and Caco-2 Cells J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1406 - 1415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Nardone, E Buffone, I Florio, and F Tezzon Changes in motor cortex excitability during muscle fatigue in amyotrophic lateral sclerosis J. Neurol. Neurosurg. Psychiatry, March 1, 2005; 76(3): 429 - 431. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Maekawa, S. Al-Sarraj, M. Kibble, S. Landau, J. Parnavelas, D. Cotter, I. Everall, and P. N. Leigh Cortical selective vulnerability in motor neuron disease: a morphometric study Brain, June 1, 2004; 127(6): 1237 - 1251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kalra, N. R. Cashman, Z. Caramanos, A. Genge, and D. L. Arnold Gabapentin Therapy for Amyotrophic Lateral Sclerosis: Lack of Improvement in Neuronal Integrity Shown by MR Spectroscopy AJNR Am. J. Neuroradiol., March 1, 2003; 24(3): 476 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Dauper, T. Peschel, C. Schrader, C. Kohlmetz, G. Joppich, W. Nager, R. Dengler, and J. D. Rollnik Effects of subthalamic nucleus (STN) stimulation on motor cortex excitability Neurology, September 10, 2002; 59(5): 700 - 706. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
